about
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityRisks on N-acetyltransferase 2 and bladder cancer: a meta-analysisGenetic modifiers of cancer risk in Lynch syndrome: a reviewPolymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancerAssociation of the NuMA region on chromosome 11q13 with breast cancer susceptibility.The associations between two vital GSTs genetic polymorphisms and lung cancer risk in the Chinese population: evidence from 71 studies.No association of GSTM1 null polymorphism with endometriosis in women from central and southern IranCandidate gene case-control association studies: advantages and potential pitfalls.Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.The GSTP1 105Val allele increases breast cancer risk and aggressiveness but enhances response to cyclophosphamide chemotherapy in North ChinaEpithelial ovarian cancer: influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression.Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions.Allelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility.Association of CYP3A4 genotype with treatment-related leukemia.Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk.Identification of genetic variants and gene expression relationships associated with pharmacogenes in humansGSTM1 and GSTP1 polymorphisms as potential factors for modifying the effect of smoking on inflammatory response.Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis.Genetics and epigenetics of varicocele pathophysiology: an overview.Association of CYP3A5*3 polymorphism with development of acute leukemia.Genetic polymorphisms in glutathione S-transferase T1 affect the surgical outcome of varicocelectomies in infertile patients.Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite.Population-specific GSTM1 copy number variation.Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.
P2860
Q24679438-FF9F2A29-779E-4082-AB1E-FD63C48B5189Q26771643-1355697A-6F85-47F9-BBDA-DD09E022C665Q27004353-A889BFA4-0ECE-4CB1-8926-3E879EBD7F97Q33608783-9AA7C2FF-B5AF-4D50-B993-A397EFD7D106Q33836163-9CA282CE-82B0-4729-BEC2-09C7F5CDFCCFQ33921472-FF875DF5-F714-4FBA-89E9-716DE51ABB29Q34176393-8DA3072C-982E-49A3-A9C2-8597F679ECEAQ34459045-FD5CA69D-280B-4929-A665-3FFF4DD88631Q34528039-894F777B-D228-4A64-82A9-EB1CF1E3B3FEQ34797388-78ADBB92-6ABA-492C-B9D9-6E93C07D760CQ36141177-BDF61FCA-DEA7-4FB6-832E-4A98719F9FD1Q36497020-C3FCEDFF-D571-487E-990A-CAD84328364AQ36617324-9B3CB072-6B86-4A28-9360-2C7AAF5E52B3Q36643196-6F2156C2-C7CB-409B-85AE-83F04DC5E148Q36647805-162E467B-F5BE-4FEC-96AD-BAEB2F3836BDQ36935918-7EBA194C-6787-4AB0-AE6B-BC61CF14FC3DQ37292027-E85FED19-9C27-4C88-A213-ABDD007227F7Q37372729-254F30D9-7598-4F96-8103-757F77464C36Q37761616-E54E631E-BA84-4F0C-8503-3FD06C9E48B4Q38681940-C312C85A-4C6D-42C9-8B44-B1237032DDC0Q41010465-E3D6B9A6-3C9A-45E8-9EB5-CC5FC7EBEEF9Q41814179-BCC3CBF1-36A4-4F7E-896F-A0715EF930D2Q42103895-99E2E31B-EBA8-4C6F-B373-99A3E592770BQ43077031-627DEC27-FAF8-45ED-9455-F7CFB4E3E711Q44700711-FCE9269C-378A-455F-8248-6C00F17687C8
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Metabolic polymorphisms and cancer susceptibility.
@en
type
label
Metabolic polymorphisms and cancer susceptibility.
@en
prefLabel
Metabolic polymorphisms and cancer susceptibility.
@en
P2093
P1433
P1476
Metabolic polymorphisms and cancer susceptibility
@en
P2093
P577
1995-01-01T00:00:00Z